Journal
JAMA NEUROLOGY
Volume 72, Issue 1, Pages 119-122Publisher
AMER MEDICAL ASSOC
DOI: 10.1001/jamaneurol.2014.2886
Keywords
-
Categories
Funding
- US Department of Defense Breast Cancer Innovator award [BC074986]
- Wyss Institute for Biologically Inspired Engineering at Harvard University
Ask authors/readers for more resources
Obstruction of normal blood flow, which occurs in a variety of diseases, including thromboembolism in stroke and atherosclerosis, is a leading cause of death and long-term adult disability in the Western world. This review focuses on a novel nanotherapeutic drug-delivery platform that is mechanically activated within blood vessels by high-fluid shear stresses to selectively target drugs to sites of vascular obstruction. In vitro and in vivo studies have shown that this approach can be used to efficiently lyse clots using a significantly lower amount of thrombolytic drug than is required when administered in a soluble formulation. This nanotherapeutic strategy can potentially improve both the efficacy and safety of thrombolytic drugs, particularly in patients who are at high risk for brain hemorrhage, and thus provide a new approach for the treatment of many life-threatening and debilitating vascular disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available